Preparing fertility data sets for clinical studies

Table of Contents

• Introduction
• Why Preparing Fertility Data Sets Properly Matters
• The Core Challenge of Preparing Fertility Data for Clinical Studies
• Impact of Poor Data Preparation on Clinical Study Outcomes
• Types of Fertility Data Used in Clinical Studies
• Deep Dive: How Fertility Data Sets Are Built for Research Use
• Strategies to Prepare Fertility Data Sets for Clinical Studies
• Cleaning and Standardising Fertility Data Before Use
• Compliance, Consent, and Ethical Requirements
• Anonymising Patient Data for Research Purposes
• Maintaining Data Set Integrity Throughout a Study
• Overview of Data Preparation Methods and Their Benefits
• FAQs
• Conclusion

Introduction

Fertility clinics sit on some of the most detailed longitudinal patient data in all of healthcare. Stimulation protocols, laboratory outcomes, embryo development records, genetic screening results, and long-term pregnancy outcomes are collected systematically across thousands of treatment cycles every year. This data has enormous potential to advance clinical research, improve treatment protocols, and support better outcomes for future patients.

But raw clinical data collected during routine care is rarely ready for research use without significant preparation work. Records contain missing values, inconsistent formatting, duplicate entries, and coding variations that make analysis unreliable if they are not addressed before a study begins. Patient privacy obligations require that data be anonymised or pseudonymised in accordance with applicable regulations before it is used for research. And ethical and governance requirements demand that the right consent and approvals are in place before any clinical data set is assembled.

This guide explains what fertility clinics need to do to prepare their data sets properly for clinical studies, covering everything from data cleaning and standardisation to consent management, anonymisation, and ongoing data set integrity.

Why Preparing Fertility Data Sets Properly Matters?

The quality of the conclusions drawn from a clinical study is directly determined by the quality of the data on which the study is based. A research data set that contains errors, inconsistencies, or gaps will produce findings that are unreliable, difficult to replicate, and potentially misleading. In a fertility research context, where findings may influence treatment protocols used for patients in future cycles, the consequences of poor data quality extend beyond the study itself.

• Produces research findings that are reliable, reproducible, and genuinely useful for improving clinical practice
• Meets the data quality standards required by ethics committees, research bodies, and academic journals for study approval and publication
• Protects patient privacy by ensuring that data is properly anonymised before it leaves the clinical environment for research use
• Reduces the risk of study findings being challenged or retracted due to data quality problems identified after publication
• Builds the clinical and research reputation of the fertility clinic by demonstrating rigorous data management practices

Investing time in proper data preparation before a study begins is significantly more efficient than attempting to correct data quality problems after analysis has started. Problems identified early are far easier and less costly to resolve than those discovered halfway through a study or after results have been reported.

The Core Challenge of Preparing Fertility Data for Clinical Studies

The main challenge for fertility clinic software teams is that clinical data is collected for the purpose of delivering patient care, not for research. The priorities that shape how data is recorded during clinical work, speed, practicality, and immediate clinical utility, are different from the priorities that make data useful for research, completeness, consistency, and standardised coding.

Fertility clinic data sets also span long time periods during which recording conventions, software platforms, and staff teams change. A data set covering ten years of IVF cycles may contain records from three different software systems, multiple coding frameworks for the same outcome types, and varying levels of completeness depending on when each record was created and by whom.

The challenge is not simply extracting data from a clinical system. It is transforming a heterogeneous collection of clinical records into a clean, consistent, ethically compliant research data set that can support robust analysis and withstand scrutiny from peer reviewers and regulatory bodies.

Impact of Poor Data Preparation on Clinical Study Outcomes

When fertility data sets are inadequately prepared before a clinical study begins, the problems that result affect the study at every stage:

• Missing values in key variables force researchers to exclude large portions of the data set from analysis, reducing the statistical power of the study and introducing selection bias
• Inconsistent outcome coding means that the same clinical result is counted differently across different parts of the data set, making aggregate analysis meaningless
• Duplicate records inflate apparent sample sizes and distort findings if they are not identified and removed before analysis begins
• Inadequate anonymisation exposes the clinic to regulatory sanctions and erodes patient trust if patient identities can be re-identified from the research data set
• Missing or invalid consent documentation may result in the ethics committee withdrawing approval for the study or requiring records to be excluded from the data set mid-study

These problems make thorough data preparation a prerequisite for any clinical study that aims to produce findings that are valid, publishable, and genuinely useful for advancing fertility treatment.

Types of Fertility Data Used in Clinical Studies

Fertility clinical studies draw on a wide range of data types depending on their specific research question. Understanding what data is available, where it is held, and what its current quality level is forms the foundation of any data preparation plan.

• Patient demographic data including age, body mass index, and reproductive history, which is used to characterise study populations and control for confounding variables
• Stimulation protocol data covering drug types, doses, duration, and adjustment records across each treatment cycle
• Monitoring data from ultrasound measurements and hormone levels recorded throughout the stimulation phase
• Egg collection outcomes including oocyte count, maturity, and any procedure complications
• Fertilisation and embryology records documenting fertilisation rates, embryo development stages, and grading scores
• Genetic screening results from preimplantation genetic testing where applicable
• Transfer details including the number and developmental stage of embryos transferred and the endometrial conditions at transfer
• Pregnancy and live birth outcome data, which is often the primary endpoint in IVF outcome studies
• Cryopreservation and frozen embryo transfer records where a study includes the outcomes of frozen cycles

Each data type presents its own preparation challenges. Outcome data in particular requires careful handling because it is often recorded at different time points by different staff members and may be incomplete for patients who did not return to the clinic for outcome confirmation.

Deep Dive: How Fertility Data Sets Are Built for Research Use

Building a research-ready fertility data set starts with a clearly defined study protocol that specifies the research question, the patient population to be included, the variables required, the time period covered, and the exclusion criteria that will be applied. This protocol drives every subsequent decision about what data to extract, how to clean it, and how to handle missing or ambiguous values.

The extraction process pulls the required variables from the clinical system for all patients who meet the inclusion criteria. At this stage the data is still in its raw clinical form, with all the inconsistencies and gaps that reflect how it was originally recorded. The cleaning phase then works through the extracted data systematically, addressing missing values, standardising coding, removing duplicates, and applying the exclusion criteria defined in the study protocol.

Once the data has been cleaned and validated, identifiable information is removed or replaced with pseudonymous codes in accordance with the anonymisation requirements of the applicable regulatory framework and the ethics committee approval. The resulting research data set is then locked and version-controlled so that the exact data used in the analysis can be reproduced and audited if required.

Strategies to Prepare Fertility Data Sets for Clinical Studies

Effective data set preparation for fertility clinical studies requires a structured approach that covers every stage from initial planning through to the final research-ready file.

• Define the study protocol in full before extracting any data, including the inclusion and exclusion criteria, the required variables, and the handling rules for missing values
• Conduct a data availability assessment before committing to a study design, confirming that the required variables are actually present and sufficiently complete in the clinical system for the time period the study will cover
• Assign a named data manager who is responsible for the extraction, cleaning, anonymisation, and version control of the research data set throughout the study
• Document every transformation applied to the data during preparation, including what was changed, why, and by whom, so that the preparation process is fully transparent and auditable
• Lock the final research data set before analysis begins and preserve the original extracted data separately so that the preparation steps can be reviewed or repeated if needed

Data preparation procedures should be reviewed and updated at the start of each new study rather than assuming that the approach used for a previous study will be appropriate for a different research question or time period.

Cleaning and Standardising Fertility Data Before Use

Data cleaning is the process of identifying and resolving quality problems in the extracted data set before analysis begins. In a fertility research context, this typically involves several distinct types of work carried out in sequence.

Duplicate identification removes records that represent the same patient or the same cycle recorded more than once. In data sets drawn from multiple systems or covering periods where records were migrated between platforms, duplicates may not be immediately obvious and require probabilistic matching against identifying fields to detect reliably.

Missing value analysis assesses how many records are missing each required variable and whether the pattern of missing data is random or systematic. Systematic missing data, where a variable is consistently absent for a particular time period or patient group, indicates a recording workflow problem rather than random data entry gaps and may require a different analytical approach or an adjustment to the study inclusion criteria.

Coding standardisation replaces inconsistent outcome labels with a single defined code for each distinct value. Where a clinic has recorded embryo grades using different grading systems at different points in time, or where outcome terminology changed when a new software platform was introduced, all records need to be mapped to a single consistent coding framework before aggregate analysis is possible.

Compliance, Consent, and Ethical Requirements

Using patient clinical data for research purposes requires a clear legal and ethical basis that goes beyond the consent given for treatment. The specific requirements depend on the jurisdiction, the type of study, and whether the data will be used in identifiable or anonymised form, but certain baseline obligations apply in virtually all fertility research contexts.

• Obtain ethics committee approval for the study before any data extraction begins, and confirm that the approval covers the specific data types and time periods the study will use
• Confirm that the consent given by patients at registration or during treatment covers the use of their data for research, or that an alternative legal basis for research use is documented
• Maintain a record of the consent or legal basis for each patient whose data is included in the research data set
• Comply with HIPAA research provisions or equivalent national legislation governing the use of health data for research, including any requirements for data use agreements with external research partners
• Report any data security incidents affecting the research data set to the relevant authority in accordance with applicable breach notification requirements

Donor-related data requires particular care in a research context. The use of donor records in clinical studies may be subject to additional restrictions under fertility-specific regulations that go beyond the general rules governing medical research data. These requirements should be confirmed with the clinic’s legal advisors before any donor data is included in a research data set.

Anonymising Patient Data for Research Purposes

Anonymisation removes or replaces identifying information so that individual patients cannot be identified from the research data set. The standard required for effective anonymisation in a fertility research context is high, because the specificity of reproductive data, particularly when combined with demographic variables such as age, location, and treatment dates, can make re-identification possible even after obvious identifiers have been removed.

Pseudonymisation replaces direct identifiers such as name, date of birth, and patient ID with a research code. The mapping between the research code and the original patient identity is held separately and securely, allowing records to be linked back to their source if required for a clinical reason but preventing the research data set itself from being used to identify individuals.

For studies where full anonymisation is required rather than pseudonymisation, additional steps may be needed to reduce the risk of re-identification from combinations of indirect variables. Date variables may need to be shifted or replaced with age-at-event values. Rare clinical characteristics or outcome combinations may need to be generalised or suppressed. The specific measures required depend on the size and nature of the data set and should be assessed by a data protection specialist before the research data set is released for use.

Maintaining Data Set Integrity Throughout a Study

Data set integrity does not end at the point of preparation. Throughout the course of a clinical study, the research data set must remain consistent, version-controlled, and protected against unauthorised access or modification. Changes to the data set after analysis has begun must be documented with a clear explanation of why the change was made and what effect it has on any results already produced.

Access to the research data set should be restricted to the members of the study team who need it for their specific role in the project. Each access event should be logged automatically so that an audit trail is maintained from the point of data extraction through to study completion. If the data set is shared with an external research partner or academic institution, a data sharing agreement should be in place that specifies how the data may be used, stored, and destroyed at the end of the study.

At the conclusion of the study, the research data set and all associated documentation including the data preparation log, the anonymisation record, and the ethics approval should be archived in a secure location for the period required by the applicable regulatory framework. This archive allows the study to be audited, reproduced, or extended in future without needing to rebuild the data set from scratch.

Overview of Data Preparation Methods and Their Benefits

FAQs

Do fertility clinics need ethics committee approval to use their own patient data for research?

In most cases yes. Using identifiable patient data for research purposes beyond the direct care of the individual patient requires ethics committee approval regardless of whether the data originates from the clinic’s own records. The specific requirements vary by jurisdiction and study type. Some retrospective studies using fully anonymised data may qualify for expedited review or exemption, but this should be confirmed with the relevant ethics body before any data is extracted.

How should missing outcome data be handled in a fertility research data set?

The approach to missing outcome data should be defined in the study protocol before analysis begins. Common approaches include excluding records with missing values for the primary outcome variable, using statistical imputation methods to estimate missing values based on available data, or conducting a sensitivity analysis that tests whether the study conclusions change depending on how missing values are handled. The chosen approach should be transparently reported in the study findings.

What is the difference between anonymisation and pseudonymisation in a research context?

Anonymisation removes identifying information permanently so that the individual cannot be re-identified under any circumstances. Pseudonymisation replaces identifiers with a code, with the mapping between the code and the original identity held separately. Pseudonymised data is still considered personal data under most privacy regulations because re-identification is theoretically possible. Fully anonymised data is generally no longer subject to data protection law, but achieving true anonymisation in a fertility research data set requires careful assessment of re-identification risk.

Can fertility research data be shared with external academic institutions?

Yes, provided that the sharing arrangement complies with the applicable data protection legislation, the ethics committee approval covers external sharing, and a formal data sharing agreement is in place with the receiving institution. The agreement should specify the permitted uses of the data, the security standards the receiving institution must maintain, and the requirement to destroy or return the data at the end of the study.

How long should research data sets be retained after a study is completed?

Retention requirements for research data sets vary by funding body, journal, and regulatory framework, but a minimum of ten years from the date of publication is commonly required to allow for audit, replication, and follow-up studies. Some funding bodies and research institutions specify longer retention periods. The retention requirement should be confirmed at the start of the study and factored into the data management and storage plan from the outset.

Conclusion

Fertility clinics hold data that has the potential to contribute meaningfully to the advancement of reproductive medicine. Realising that potential requires more than extracting records from a clinical system. It requires a disciplined preparation process that produces a clean, consistent, ethically compliant, and well-documented research data set that can support robust analysis and withstand the scrutiny of ethics committees, peer reviewers, and regulatory bodies. Clinics that invest in building proper data preparation processes, from the initial availability assessment through to anonymisation, version control, and post-study archiving, create a research capability that grows stronger with every study completed. By treating data preparation as a core part of clinical research rather than a preliminary administrative step, fertility clinics can ensure that the insights their data holds translate into findings that genuinely improve outcomes for future patients.